Children as young as 12 have an elevated risk of heart inflammation after receiving Pfizer’s COVID-19 vaccine, according to a new study.
Researchers with the U.S. Food and Drug Administration (FDA) and other institutions analyzed data from the FDA’s Biologics Effectiveness and Safety Initiative and looked for safety signals after Pfizer vaccination for children aged 5 to 17 between 2021 and mid-2022.
